As of 2026-03-28, the EV/EBITDA ratio of Eli Lilly and Co (LLY) is 27.21. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LLY's latest enterprise value is 863,731.50 mil USD. LLY's TTM EBITDA according to its financial statements is 31,748.80 mil USD. Dividing these 2 quantities gives us the above LLY EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 7.4x - 8.8x | 7.9x |
| Forward P/E multiples | 10.9x - 12.5x | 12.3x |
| Fair Price | 213.04 - 440.16 | 331.28 |
| Upside | -75.7% - -49.9% | -62.3% |
| Date | EV/EBITDA |
| 2026-03-27 | 27.21 |
| 2026-03-26 | 27.76 |
| 2026-03-25 | 28.34 |
| 2026-03-24 | 27.94 |
| 2026-03-23 | 28.17 |
| 2026-03-20 | 28.05 |
| 2026-03-19 | 28.37 |
| 2026-03-18 | 28.39 |
| 2026-03-17 | 28.75 |
| 2026-03-16 | 30.50 |
| 2026-03-13 | 30.38 |
| 2026-03-12 | 30.15 |
| 2026-03-11 | 30.82 |
| 2026-03-10 | 30.86 |
| 2026-03-09 | 31.07 |
| 2026-03-06 | 30.54 |
| 2026-03-05 | 30.33 |
| 2026-03-04 | 30.93 |
| 2026-03-03 | 31.05 |
| 2026-03-02 | 31.36 |
| 2026-02-27 | 32.37 |
| 2026-02-26 | 31.48 |
| 2026-02-25 | 31.68 |
| 2026-02-24 | 32.08 |
| 2026-02-23 | 32.56 |
| 2026-02-20 | 31.11 |
| 2026-02-19 | 31.51 |
| 2026-02-18 | 31.43 |
| 2026-02-17 | 31.89 |
| 2026-02-13 | 32.01 |
| 2026-02-12 | 31.96 |
| 2026-02-11 | 31.27 |
| 2026-02-10 | 31.57 |
| 2026-02-09 | 32.15 |
| 2026-02-06 | 32.55 |
| 2026-02-05 | 31.44 |
| 2026-02-04 | 34.01 |
| 2026-02-03 | 30.93 |
| 2026-02-02 | 32.13 |
| 2026-01-30 | 31.93 |
| 2026-01-29 | 31.54 |
| 2026-01-28 | 31.53 |
| 2026-01-27 | 32.00 |
| 2026-01-26 | 32.69 |
| 2026-01-23 | 32.73 |
| 2026-01-22 | 33.42 |
| 2026-01-21 | 33.16 |
| 2026-01-20 | 32.05 |
| 2026-01-16 | 31.96 |
| 2026-01-15 | 31.80 |